CASSIE BUGAY: Open Payments
NPI 1326716796 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 86 payments from 38 companies in 2025. Trend: 2023 $687 · 2024 $1,722 · 2025 $2,189
Food & beverage: $1,897Education: $292
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $288 |
| Merck Sharp & Dohme LLC | 5 | $132 |
| Regeneron Healthcare Solutions, Inc. | 5 | $130 |
| AstraZeneca Pharmaceuticals LP | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| GENZYME CORPORATION | 3 | $100 |
| SEAGEN INC. | 1 | $100 |
| Janssen Biotech, Inc. | 4 | $88 |
| Daiichi Sankyo Inc. | 3 | $82 |
| PFIZER INC. | 4 | $80 |
Products named: LIBTAYO, KEYTRUDA, NINLARO, REBLOZYL, BRUKINSA, Padcev, Nubeqa, KISQALI.
Industry payments across GA — which companies pay providers there.
